CVS Caremark plans $6 billion share buyback

WOONSOCKET – CVS Caremark Corp., the largest provider of prescription drugs in the U.S., plans to buy back as much as $6 billion in shares, Bloomberg News reported last month. More
This item is available in full to subscribers. If you are a current subscriber, log in to continue.

You can access an additional 12 stories by registering for a free account. Click here to continue.

Otherwise, purchase a subscription to continue.

You can also purchase this single article, if you prefer. Click here to continue.
retail

CVS Caremark plans $6 billion share buyback

Posted 10/1/12

WOONSOCKET – CVS Caremark Corp., the largest provider of prescription drugs in the U.S., plans to buy back as much as $6 billion in shares, Bloomberg News reported last month.

The repurchase authorization is effective immediately and will take place over multiple years, the Woonsocket -based company said in a statement.

CVS plans to repurchase $3 billion to $4 billion annually in shares over the next several years, Chief Financial Officer David Denton told analysts Sept. 5. The retailer has gained customers after Walgreen Co. last year ended a contract to sell prescriptions through employee-benefits manager Express Scripts Holding Co. •

No comments on this story | Add your comment
Please log in or register to add your comment
Calendar
PBN Hosted
Events

The 2nd Annual Healthiest Employers event will recognize employers who have strong, effective Health and Wellness programs in the region. Deadline for enrollment is June 28th.
Advertisement
National
Local
Latest News